Tejas Savant

Stock Analyst at Morgan Stanley

(0)
# 4499
Out of 5,347 analysts
298
Total ratings
32.09%
Success rate
-14.12%
Average return
39 Stocks
Name Action PT Current % Upside Ratings Updated
CTKB Cytek Biosciences
Maintains: Equal-Weight
9 7
2.79 150.9% 9 May 28, 2025
TXG 10x Genomics
Maintains: Overweight
26 18
9.53 88.88% 14 May 19, 2025
ILMN Illumina
Maintains: Equal-Weight
136 100
82.29 21.52% 8 May 12, 2025
TEM Tempus AI
Maintains: Overweight
60 65
55.2 17.75% 3 May 9, 2025
HOLX Hologic
Maintains: Equal-Weight
77 65
62.16 4.57% 9 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
8 7
6 16.67% 2 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 9
9.51 -5.36% 12 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 10
7.28 37.36% 13 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
25 15
12.92 16.1% 17 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
2.25 122.22% 13 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
16 20
38.34 -47.84% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
176 185
157.7 17.31% 13 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
245 250
140.25 78.25% 11 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
647 678
402.75 68.34% 14 Jan 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Equal-Weight
24 23
22.21 3.56% 1 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
26 28
26.61 5.22% 12 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
32 21
4.2 400% 2 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
4 2
0.96 108.33% 11 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 3
1.24 141.94% 10 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 40
6.94 476.37% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 26
n/a n/a 12 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 8
n/a n/a 11 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
52 55
n/a n/a 11 Aug 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1
n/a n/a 1 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
6 6
0.75 700% 3 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 10
3.01 232.23% 8 May 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
3
3.33 -17.42% 6 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 5
4.63 7.99% 12 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 10
1.93 418.13% 10 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
80 73
40.66 79.54% 9 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 2
n/a n/a 5 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
n/a n/a 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 5
n/a n/a 8 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
350 250
135.66 84.28% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
0.3 1566.67% 5 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
n/a n/a 3 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 17
n/a n/a 8 May 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
21 20
n/a n/a 2 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
35 65
n/a n/a 1 Feb 22, 2021